威廉亚洲博彩公司 &解读威廉亚洲博彩公司

MedSci主页 / 所有栏目 / 威廉亚洲博彩公司 &解读威廉亚洲博彩公司

2020 NICE威廉亚洲博彩公司 :静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测(NG.158)

2020-03-26 英国国家卫生与临床优化研究所 NICE官网

2020年3月,英国国家卫生与临床优化研究所 (NICE)发布了静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测威廉亚洲博彩公司 。文章主要内容涵盖了成人静脉血栓栓塞性疾病的诊断和管理的相关内容,目的是为深静脉血栓

中文标题:

2020 NICE威廉亚洲博彩公司 :静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测(NG.158)

英文标题:

NICE guideline [NG158]:Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

发布日期:

2020-03-26

简要介绍:

2020年3月,英国国家卫生与临床优化研究所 (NICE)发布了静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测威廉亚洲博彩公司 。文章主要内容涵盖了成人静脉血栓栓塞性疾病的诊断和管理的相关内容,目的是为深静脉血栓形成(DVT)或肺栓塞(PE)患者的快速诊断和有效治疗提供支持。威廉亚洲博彩公司 同时也包含了可能发生DVT或PE的疾病的监测,如血栓形成倾向(凝血障碍)和癌症。

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=5bfa91c00188e567, title=2020 NICE威廉亚洲博彩公司 :静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测(NG.158), enTitle=NICE guideline [NG158]:Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, guiderFrom=NICE官网, authorId=0, author=, summary=2020年3月,英国国家卫生与临床优化研究所 (NICE)发布了静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测威廉亚洲博彩公司 。文章主要内容涵盖了成人静脉血栓栓塞性疾病的诊断和管理的相关内容,目的是为深静脉血栓, cover=https://img.medsci.cn/202043/1585914256673_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定威廉亚洲博彩公司 ,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供威廉亚洲博彩公司 。, copyright=0, guiderPublishedTime=Thu Mar 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p style="color: #373737;">2020年3月,英国国家卫生与临床优化研究所 (NICE)发布了静脉血栓栓塞性疾病的诊断,管理和血栓形成倾向检测威廉亚洲博彩公司 。文章主要内容涵盖了成人静脉血栓栓塞性疾病的诊断和管理的相关内容,目的是为深静脉血栓形成(DVT)或肺栓塞(PE)患者的快速诊断和有效治疗提供支持。威廉亚洲博彩公司 同时也包含了可能发生DVT或PE的疾病的监测,如血栓形成倾向(凝血障碍)和癌症。</p>, tagList=[TagDto(tagId=582, tagName=静脉血栓), TagDto(tagId=7009, tagName=血栓形成)], categoryList=[CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1169, guiderKeyword=血栓, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8751, appHits=791, showAppHits=7, pcHits=2170, showPcHits=8042, likes=9, shares=51, comments=30, approvalStatus=1, publishedTime=Fri Apr 03 20:02:30 CST 2020, publishedTimeString=2020-03-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Apr 03 19:44:23 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:41:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (24)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188064, encodeId=c7c61188064e4, content=学习到了,真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0636481752, createdName=ms8000000682510655, createdTime=Tue Jan 25 17:13:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052817, encodeId=6689105281efb, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55e25144579, createdName=14682f06m67暂无昵称, createdTime=Sat Sep 18 15:48:49 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975858, encodeId=3e079e585860, content=想下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/59fa4a85822640acaf1a75ada67f3ebb/117bfecd3b804de688fc6436387eca7f.jpg, createdBy=64c35530862, createdName=宋小草, createdTime=Tue Jun 22 17:37:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969285, encodeId=c2cb9692853b, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/2e13a288313549528be3c96593f36c60/06dfa15172294347a190eb51e97ad3a6.jpg, createdBy=ff8e1763897, createdName=博宇1975, createdTime=Fri May 28 20:46:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922739, encodeId=c75c922e3953, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2f3029993, createdName=2110749339, createdTime=Thu Feb 04 11:03:37 CST 2021, time=2021-02-04, status=1, ipAttribution=)]
    2022-01-25 ms8000000682510655

    学习到了,真好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188064, encodeId=c7c61188064e4, content=学习到了,真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0636481752, createdName=ms8000000682510655, createdTime=Tue Jan 25 17:13:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052817, encodeId=6689105281efb, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55e25144579, createdName=14682f06m67暂无昵称, createdTime=Sat Sep 18 15:48:49 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975858, encodeId=3e079e585860, content=想下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/59fa4a85822640acaf1a75ada67f3ebb/117bfecd3b804de688fc6436387eca7f.jpg, createdBy=64c35530862, createdName=宋小草, createdTime=Tue Jun 22 17:37:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969285, encodeId=c2cb9692853b, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/2e13a288313549528be3c96593f36c60/06dfa15172294347a190eb51e97ad3a6.jpg, createdBy=ff8e1763897, createdName=博宇1975, createdTime=Fri May 28 20:46:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922739, encodeId=c75c922e3953, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2f3029993, createdName=2110749339, createdTime=Thu Feb 04 11:03:37 CST 2021, time=2021-02-04, status=1, ipAttribution=)]
    2021-09-18 14682f06m67暂无昵称

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188064, encodeId=c7c61188064e4, content=学习到了,真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0636481752, createdName=ms8000000682510655, createdTime=Tue Jan 25 17:13:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052817, encodeId=6689105281efb, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55e25144579, createdName=14682f06m67暂无昵称, createdTime=Sat Sep 18 15:48:49 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975858, encodeId=3e079e585860, content=想下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/59fa4a85822640acaf1a75ada67f3ebb/117bfecd3b804de688fc6436387eca7f.jpg, createdBy=64c35530862, createdName=宋小草, createdTime=Tue Jun 22 17:37:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969285, encodeId=c2cb9692853b, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/2e13a288313549528be3c96593f36c60/06dfa15172294347a190eb51e97ad3a6.jpg, createdBy=ff8e1763897, createdName=博宇1975, createdTime=Fri May 28 20:46:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922739, encodeId=c75c922e3953, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2f3029993, createdName=2110749339, createdTime=Thu Feb 04 11:03:37 CST 2021, time=2021-02-04, status=1, ipAttribution=)]
    2021-06-22 宋小草

    想下载

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188064, encodeId=c7c61188064e4, content=学习到了,真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0636481752, createdName=ms8000000682510655, createdTime=Tue Jan 25 17:13:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052817, encodeId=6689105281efb, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55e25144579, createdName=14682f06m67暂无昵称, createdTime=Sat Sep 18 15:48:49 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975858, encodeId=3e079e585860, content=想下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/59fa4a85822640acaf1a75ada67f3ebb/117bfecd3b804de688fc6436387eca7f.jpg, createdBy=64c35530862, createdName=宋小草, createdTime=Tue Jun 22 17:37:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969285, encodeId=c2cb9692853b, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/2e13a288313549528be3c96593f36c60/06dfa15172294347a190eb51e97ad3a6.jpg, createdBy=ff8e1763897, createdName=博宇1975, createdTime=Fri May 28 20:46:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922739, encodeId=c75c922e3953, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2f3029993, createdName=2110749339, createdTime=Thu Feb 04 11:03:37 CST 2021, time=2021-02-04, status=1, ipAttribution=)]
    2021-05-28 博宇1975

    好好学习天天向上

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188064, encodeId=c7c61188064e4, content=学习到了,真好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0636481752, createdName=ms8000000682510655, createdTime=Tue Jan 25 17:13:16 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052817, encodeId=6689105281efb, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55e25144579, createdName=14682f06m67暂无昵称, createdTime=Sat Sep 18 15:48:49 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975858, encodeId=3e079e585860, content=想下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/59fa4a85822640acaf1a75ada67f3ebb/117bfecd3b804de688fc6436387eca7f.jpg, createdBy=64c35530862, createdName=宋小草, createdTime=Tue Jun 22 17:37:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969285, encodeId=c2cb9692853b, content=好好学习天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210528/2e13a288313549528be3c96593f36c60/06dfa15172294347a190eb51e97ad3a6.jpg, createdBy=ff8e1763897, createdName=博宇1975, createdTime=Fri May 28 20:46:39 CST 2021, time=2021-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922739, encodeId=c75c922e3953, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e2f3029993, createdName=2110749339, createdTime=Thu Feb 04 11:03:37 CST 2021, time=2021-02-04, status=1, ipAttribution=)]
    2021-02-04 2110749339

    很好

    0

拓展阅读

2009 ASGE威廉亚洲博彩公司 :抗血栓药物在内镜操作时的管理

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2009-11-03

2010 EFNS 成人脑静脉窦血栓形成的治疗威廉亚洲博彩公司

欧洲神经科学协会联盟(EFNS,European Federation of Neurological Societies) · 2010-01-01

2010 急性肺血栓栓塞症诊断治疗中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2010-01-01

减少入院患者静脉血栓栓塞(深静脉血栓和肺栓塞)的风险

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2010-01-01

2010SIGN 苏格兰国家静脉血栓栓塞的预防和治疗临床威廉亚洲博彩公司

苏格兰校际威廉亚洲博彩公司 网络(SIGN,Scottish Intercollegiate Guidelines Network) · 2010-01-01

2010 ACR标准:怀疑下肢深静脉血栓形成

美国放射学会(ACR,American College of Radiology) · 2010-01-01